Reviticell has developed an innovative medical device that is the foundation for a family of Reviticell Kit products. Patent-pending Reviticell Kits will make regenerative medicine treatments available on a massive scale with numerous applications ranging from wound-care in battlefield hospitals to anti-aging in Beverly Hills clinics.
The promise of regenerative medicine is that it can leverage the power within your own body to heal you or to change the course of disease.
For example, every month millions of people get Cortisone shots — a foreign substance being injected into your body. While Cortisone may alleviate pain in the short-term it will not cure the underlying problem and may cause complications.
Regenerative medicine gives you a totally different option.
A doctor can take a small amount of your blood and prepare your blood cells for a therapeutic treatment. This personalized treatment can alleviate your pain and can also accelerate your natural healing process without causing complications.
There are actually hundreds of therapies that are possible by preparing your blood or tissue that exist within your own body — each represent a unique revenue-stream in the Reviticell business model.
As a result of demands from the industry and the FDA, Reviticell Kits were developed so that doctors can safely and efficiently prepare regenerative medicine treatments with predictable and consistent outcomes. Doctors will be able to be as confident when using treatments prepared with Reviticell Kits as they would be with pharmaceutical treatments manufactured in highly-regulated labs. Treatments prepared with Reviticell Kits, however, can also provide doctors with confidence that their patients’ bodies will accept these treatments since each patient’s body is the source of their own treatment.
One System for Many Therapies
The inherent flexibility of the Reviticell Kit system makes it highly scalable. Reviticell’s modular, single-use, kit-based system can be configured for numerous treatment preparation protocols. This flexibility is what will allow Reviticell Kits to make regenerative medicine treatments available on a massive scale.
Poised and Ready for Success
Reviticell has the capacity to commercialize and immediately scale-up by leveraging world-class resources that have an existing market presence.
Reviticell will leverage a variety of best-in-class companies to support manufacturing, sales, and distribution of Reviticell Kits. By leveraging third-party resources, Reviticell can avoid the capital costs that would otherwise be required and the time-lag that would otherwise occur.
World Class Presence
Thanks to a relationship and an agreement with University of Florida, John Murray, MD, who leads the Regenerative Medicine program at UF Health Jacksonville also serves as Reviticell Chief Medical Officer. This unique arrangement allows Reviticell to stay at the leading edge of this exciting industry. In addition, it makes it possible for Reviticell to leverage the immense resources of the University of Florida and the universities with whom they collaborate.
Reviticell Kits will initially be produced for Blood Preparation and Tissue Preparation. Within both revenue streams there is the potential for multiple Reviticell Kit types — each of which can be configured and branded for a variety of medical practice markets.
Reviticell’s management team has extensive experience in product and business development, marketing and sales, and managing successful high-growth businesses in multiple markets in the United States and abroad. This team has laid the groundwork so that systems are in place and resources are ready for Reviticell’s rapid growth.
Patent-pending Reviticell Kits will be unique in the industry because each kit will provide the exact combination of components necessary to prepare a specific regenerative medicine treatment. This standardized system and preparation process will make predictable and consistent outcomes possible. In addition, medical costs and the risk of medical error can be reduced.
The International Search Authority provided Reviticell with a Written Opinion which states that 55 Reviticell patent claims are novel, inventive, and have industrial applicability.
This favorable Written Opinion will allow Reviticell to take advantage of an accelerated examination review in the US and around the world. These 55 claims are the foundation of the Reviticell Kits system and the family of Reviticell Kit products.
55 Patent Claims Validated by the International Search Authority
The emerging field of regenerative medicine is projected to grow to an $83 billion industry by 2020 and Reviticell Kits are uniquely positioned to become the industry standard.